QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 reviva-pharmaceuticals-q3-eps-006-beats-010-estimate

Reviva Pharmaceuticals (NASDAQ:RVPH) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate o...

 d-boral-capital-maintains-buy-on-reviva-pharmaceuticals-maintains-2-price-target

D. Boral Capital analyst Jason Kolbert maintains Reviva Pharmaceuticals (NASDAQ:RVPH) with a Buy and maintains $2 price target.

 hc-wainwright--co-maintains-buy-on-reviva-pharmaceuticals-lowers-price-target-to-4

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Reviva Pharmaceuticals (NASDAQ:RVPH) with a Buy and lowers the ...

 this-vse-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

 chardan-capital-initiates-coverage-on-reviva-pharmaceuticals-with-buy-rating-announces-price-target-of-2

Chardan Capital analyst Rudy Li initiates coverage on Reviva Pharmaceuticals (NASDAQ: RVPH) with a Buy rating and announces ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION